Daniel L. Shores
Primary Areas of Practice
"Dan is an exceptional patent lawyer and strategist who delivers great results for us time and again. He is an invaluable asset to our team."
- Client Testimonial
Overview
Dan Shores is a Partner at Rothwell Figg and is a founder of its Boston office. He is passionate about helping his clients build robust patent portfolios, litigate matters (both as plaintiffs and defendants in the U.S. District Courts and in IPR and other post-grant proceedings), protect trade secrets, negotiate strategic collaborations, conduct due diligence and landscape investigations, and prepare for success in funding rounds and exits. Dan is a problem-solver who excels at deciphering key translational aspects of a broad array of technologies to maximize leverage in the context of clients’ desired implementation of such technologies whether as participants in dynamic markets or as first movers. Dan is a registered patent attorney licensed to practice before the United States Patent and Trademark Office, and is admitted to practice law in Massachusetts and in the District of Columbia. He is a member of the bars of the Supreme Court of the United States, United States Court of Appeals for the Federal Circuit, and United States District Court for the District of Massachusetts. Dan lives in Boston with his wife Lindsay, their daughter Audrey, and their two English Bulldogs Jarves and Rosie.
Newsroom
News
Speaking Engagements
Publications
Author, mRNA IP 2022 Year in Review: Pioneers Clash in Major Patent Litigation, IPWatchdog.com, January 1, 2023
Author, COVID-19 Patent Wars: mRNA and Lipid Nanoparticle Pioneers Clash over Vaccine Delivery Patents, ABA Landslide® Magazine, September 28, 2022
Author, The mRNA Patent and Competitive Landscape: Pioneers, Litigation Outlook and Big Pharma's Next Moves (Part III), IPWatchdog.com, April 30, 2021
Co-Author, The mNRA IP and Competitive Landscape: Translate BIO; Arcturus; eTheRNA and Other Startups; and LNP Technology (Part II), IPWatchdog.com, April 21, 2021
Co-Author, The mRNA IP and Competitive Landscape Through One Year of the COVID-19 Pandemic (Part I), IPWatchdog.com, April, 11, 2021
Co-Author, IP Assignment Considerations for Emerging Companies, rfemerge.com, March 26, 2021
Co-Author, Emerging Companies: Framework for Leveraging Your IP & Tech, rfemerge.com, December 4, 2020
Author, Breaking Down Moderna's COVID-19 Patent Pledge: Why Did They Do It?, IPWatchdog.com, November 11, 2020
Co-Author, Key Considerations Regarding Early Disclosures and Patent Protection, rfemerge.com, October 18, 2020
Author, Critical Steps for Building Winning Patent Portfolios, rfemerge.com, October 6, 2020
Community & Professional
American Intellectual Property Law Association (AIPLA)
Boston Patent Law Association (BPLA)
Intellectual Property Owners Association (IPO)
Member of the Pharmaceuticals & Biotechnology Issues Committee
Chairman of the Board of Trustees for Massachusetts Maritime Academy
Practices
- Artificial Intelligence
- Brand Protection
- Counseling, Transactions, and Guidance
- Due Diligence
- Emerging Companies
- Hatch-Waxman Litigation
- Inter Partes Review (IPR) and Post Grant Review (PGR)
- International Filings
- International Trade Commission (ITC) Litigation
- Licensing and Transactions
- Opinions, Freedom to Operate, and Patentability Analysis
- Patent Litigation
- Patent Prosecution
- Patent Strategy and Counseling
- Portfolio Management
- Trade Secret Litigation
- Trademark Prosecution
Education
J.D., Georgetown University Law Center
B.S., Specialization in Materials Science, University of New Hampshire
Bar & Court Admissions
Bar Admissions
- District of Columbia
- Massachusetts
- U.S. Patent and Trademark Office
Court Admissions
- U.S. Supreme Court
- U.S. Court of Appeals for the Federal Circuit
- U.S. District Court for the Commonwealth of Massachusetts